Buyback of Class B shares in Essity during week 12, 2026
Between March 16, 2026, and March 19, 2026, Essity Aktiebolag (publ) repurchased a total of 406,220 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The buyback program that was initiated on April 24, 2025, is hereby completed as a total of 11,566,941 Class B shares have been repurchased for a total amount of SEK 3bn.
The share repurchase has been financed using cash flow from current operations after the ordinary dividend. The ambition is to continue with share buybacks over time as a recurring part of Essity’s capital allocation.
The share purchase has been completed nd be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission’s Delegated Regulation 2016/1052 (Safe Harbour Regulation).
Class B shares in Essity were repurchased as follows:
| Date | Aggregated daily volume (no. of shares): | Weighted average price per day (SEK): | Total daily transaction value (SEK): |
| March 16, 2026 | 49,418 | 263.6346 | 13,028,295 |
| March 17, 2026 | 49,756 | 263.2290 | 13,097,222 |
| March 18, 2026 | 175,694 | 256.1877 | 45,010,642 |
| March 19, 2026 | 131,352 | 252.8429 | 33,211,421 |
| Total accumulated during week 12 2026 | 406,220 | 256.8745 | 104,347,579 |
| Total accumulated during the buyback program | 11,566,941 | 259.3598 | 2,999,999,752 |
All purchases were conducted on Nasdaq Stockholm by BofA Securities Europe SA on behalf of Essity. Following the above purchases, Essity’s holding of treasury shares amounted on March 19, 2026, to 12,349,441 Class B shares. The total number of shares in Essity amounted on the date of this press release to 693,054,489, of which 57,200,658 Class A shares and 635,853,831 Class B shares.
For additional information, please contact:
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com
Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2025, Essity had net sales of approximately SEK 138bn (EUR 13bn) and employed 36,000 people. The company’s headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.
Tags: